Norwich NR592 Week 3 Discussion Latest 2022 September
Question # 00830558
Posted By:
Updated on: 09/04/2022 11:09 AM Due on: 09/04/2022
NR592 PMHNP - Population Focus Pharmacology
Week 3 Discussion
New monoamine agonists: Choose one of the new monoamine agonists. Discuss risks and benefits of choosing one of these newer medications to treat your patients’ anxiety and depression. Why might you choose a newer one rather than an older one? Elaborate on a case where a newer agent might be helpful and why.
Dopamine blockers: Why is dopamine dosed differently for different conditions? Choose a diagnosis that you will likely treat as a provider and consider which dopamine blocker you might use and how you would dose that medication for the diagnosis chosen.
-
Rating:
/5
Solution: Norwich NR552 Week 3 Discussion Latest 2022 September